Skip to main content

Table 3 Overview of differentially expressed probes (DEPs) between the different sample groups

From: Molecular profiling of cutaneous squamous cell carcinomas and actinic keratoses from organ transplant recipients

 

SCC vs. NS

AK vs. NS

SCC vs. AK

‘Progression’

# of samples

15 vs. 13

14 vs. 13

15 vs. 14

 

# of DEPs with FDR < 0.01

6820* (3333/3487)

3734 (1554/2180)

2131 (1088/1043)

658 (262/396)

# of DEPs with FDR < 0.01 and log2FC > = 0.5

2087 (1087/1009)

977 (526/451)

571 (289/282)

180 (90/90)

# of DEP with FDR < 0.01 and log2FC > = 1.0

639 (370/269)

219 (167/52)

145 (81/64)

40 (32/8)

  1. * Total number of DEPs (number of upregulated DEPs/number of downregulated DEPs).
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us